Investors need to see the forecast for Heat Biologics (HTBX)
What’s up with Heat Biologics?
Heat Biologics (HTBX) opened at $0.55, which means the stock is down 2.15% from yesterday’s closing price of 0.55. Today, the company has a high of $0.55 and a low of $0.53. The company has a market cap of $43.28 million with a 52-week high of $1.25 and a 52-week low of $0.20.
What about the future for Heat Biologics?
The high forecast for Heat Biologics is 5.00 while the low is 2.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Heat Biologics has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information HTBX seems to be a safe buy.
About Heat Biologics
Heat Biologics is a biopharmaceutical company headquartered in Morrisville, NC and has operations in San Antonio, TX. The company has a proprietary gp96 platform to activate immune responses against pathogenic or cancer antigens.